f medium

Final weeks to approval: NIH’s Anthony Fauci and FDA’s Peter Marks on what’s ahead before we can expect a safe COVID vaccine

As tens of thousands of people participate in phase 3 clinical trials on COVID-19 vaccine candidates, the focus is turning ...